Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.

@article{Cardonick2012MaternalAF,
  title={Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature.},
  author={Elyce H. Cardonick and Abdul Qayoom Bhat and Dzhamala Gilmandyar and Robert A. Somer},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2012},
  volume={23 12},
  pages={
          3016-23
        }
}
BACKGROUND The purpose of this study was to evaluate the use of taxane chemotherapy during pregnancy and compare maternal and neonatal outcomes with those in women who did not receive taxanes during pregnancy, and review current existing data. STUDY DESIGN This is a retrospective cohort study in which women were identified from the Cancer and Pregnancy Registry at Robert Wood Johnson Medical Center. A retrospective chart analysis and an independent t-test were carried out comparing patient… CONTINUE READING
Highly Cited
This paper has 32 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 13 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Ovarian cancer in pregnancy.

Best practice & research. Clinical obstetrics & gynaecology • 2017